{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:49:45Z","timestamp":1787312985668,"version":"build-2736575974"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004697","name":"Hamadan University of Medical Sciences","doi-asserted-by":"publisher","award":["9911148014"],"award-info":[{"award-number":["9911148014"]}],"id":[{"id":"10.13039\/501100004697","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.intimp.2023.110379","type":"journal-article","created":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T23:31:54Z","timestamp":1685057514000},"page":"110379","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Toxoplasma gondii attenuates the ethidium bromide induced demyelination lesions in multiple sclerosis model rats"],"prefix":"10.1016","volume":"120","author":[{"given":"Seyedmousa","family":"Motavallihaghi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojgan","family":"Ghaemipanaeian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Soleimani Asl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faeze","family":"Foroughi-Parvar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Hossein","family":"Maghsood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.intimp.2023.110379_b0005","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/jama.2020.26858","article-title":"Diagnosis and treatment of multiple sclerosis: a review","volume":"325","author":"McGinley","year":"2021","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.intimp.2023.110379_b0010","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2174\/1381612822666161214153108","article-title":"Multiple sclerosis and neuroinflammation: the overview of current and prospective therapies","volume":"23","author":"Bjelobaba","year":"2017","journal-title":"Curr. Pharm. Des."},{"issue":"3","key":"10.1016\/j.intimp.2023.110379_b0015","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S1474-4422(18)30443-5","article-title":"Global, regional, and national burden of multiple sclerosis 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"18","author":"Wallin","year":"2019","journal-title":"The Lancet Neurology"},{"issue":"8","key":"10.1016\/j.intimp.2023.110379_b0020","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S1474-4422(20)30140-X","article-title":"Remyelination in multiple sclerosis: from basic science to clinical translation","volume":"19","author":"Lubetzki","year":"2020","journal-title":"The Lancet Neurology"},{"issue":"17","key":"10.1016\/j.intimp.2023.110379_b0025","doi-asserted-by":"crossref","first-page":"6020","DOI":"10.3390\/ijms21176020","article-title":"Molecular biomarkers in multiple sclerosis and its related disorders: a critical review","volume":"21","author":"Gul","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2023.110379_b0030","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/s12974-019-1674-2","article-title":"Molecular biomarkers in multiple sclerosis","volume":"16","author":"Ziemssen","year":"2019","journal-title":"J. Neuroinflammation"},{"issue":"4","key":"10.1016\/j.intimp.2023.110379_b0035","first-page":"725","article-title":"Multiple sclerosis: Etiology, symptoms, incidence and prevalence, and implications for community living and employment","volume":"52","author":"Bishop","year":"2015","journal-title":"Work"},{"issue":"12","key":"10.1016\/j.intimp.2023.110379_b0040","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.amjmed.2020.05.049","article-title":"Treatment of multiple sclerosis: a review","volume":"133","author":"Hauser","year":"2020","journal-title":"Am. J. Med."},{"issue":"5","key":"10.1016\/j.intimp.2023.110379_b0045","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3109\/08830185.2014.941239","article-title":"International Reviews of Immunology","volume":"33","author":"Internati","year":"2014","journal-title":"Int. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110379_b0050","article-title":"Relationship of Toxoplasma Gondii Exposure with Multiple Sclerosis","volume":"13","author":"Oru\u00e7","year":"2016","journal-title":"Eur. J. Gen. Med."},{"key":"10.1016\/j.intimp.2023.110379_b0055","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s12026-013-8402-2","article-title":"Toxoplasma gondii: bystander or cofactor in rheumatoid arthritis","volume":"56","author":"Fischer","year":"2013","journal-title":"Immunol. Res."},{"key":"10.1016\/j.intimp.2023.110379_b0060","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jneuroim.2018.06.011","article-title":"Is Toxoplasma gondii playing a positive role in multiple sclerosis risk? A systematic review and meta-analysis","volume":"322","author":"Saberi","year":"2018","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110379_b0065","doi-asserted-by":"crossref","first-page":"18855","DOI":"10.1038\/s41598-020-75830-y","article-title":"Toxoplasma gondii and multiple sclerosis: a population-based case\u2013control study","volume":"10","author":"Nicoletti","year":"2020","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.intimp.2023.110379_b0070","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1177\/1352458518805246","article-title":"Animal models of multiple sclerosis: From rodents to zebrafish","volume":"25","author":"Burrows","year":"2019","journal-title":"Mult. Scler. J."},{"issue":"1","key":"10.1016\/j.intimp.2023.110379_b0075","first-page":"40","article-title":"Brain tissue cysts in infected mice with RH-strain of Toxoplasma gondii and evaluation of BAG1 and SAG1 genes expression","volume":"8","author":"Selseleh","year":"2013","journal-title":"Iran. J. Parasitol."},{"issue":"3","key":"10.1016\/j.intimp.2023.110379_b0080","first-page":"367","article-title":"In vitro and in vivo potential of RH strain of Toxoplasma gondii (Type I) in tissue cyst forming","volume":"8","author":"Asgari","year":"2013","journal-title":"Iran. J. Parasitol."},{"issue":"11","key":"10.1016\/j.intimp.2023.110379_b0085","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.3390\/cells8111439","article-title":"High speed ventral plane videography as a convenient tool to quantify motor deficits during pre-clinical experimental autoimmune encephalomyelitis","volume":"8","author":"Zhan","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.intimp.2023.110379_b0090","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2147\/ITT.S61528","article-title":"The hygiene hypothesis: current perspectives and future therapies","author":"Stiemsma","year":"2015","journal-title":"ImmunoTargets and therapy"},{"issue":"3","key":"10.1016\/j.intimp.2023.110379_b0095","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028936","article-title":"Multiple sclerosis pathology","volume":"8","author":"Lassmann","year":"2018","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.intimp.2023.110379_b0100","doi-asserted-by":"crossref","unstructured":"B.F.G. Popescu, I. Pirko, C.F. Lucchinetti, Pathology of multiple sclerosis: where do we stand?, CONTINUUM: Lifelong Learning in Neurology 19(4 Multiple Sclerosis) (2013) 901.","DOI":"10.1212\/01.CON.0000433291.23091.65"},{"issue":"2","key":"10.1016\/j.intimp.2023.110379_b0105","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1750-3639.2007.00064.x","article-title":"The immunopathology of multiple sclerosis: an overview","volume":"17","author":"Lassmann","year":"2007","journal-title":"Brain Pathol."},{"issue":"8","key":"10.1016\/j.intimp.2023.110379_b0110","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/s41582-019-0184-2","article-title":"The pro-remyelination properties of microglia in the central nervous system","volume":"15","author":"Lloyd","year":"2019","journal-title":"Nat. Rev. Neurol."},{"issue":"4","key":"10.1016\/j.intimp.2023.110379_b0115","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1084\/jem.20141656","article-title":"Inefficient clearance of myelin debris by microglia impairs remyelinating processes","volume":"212","author":"Lampron","year":"2015","journal-title":"J. Exp. Med."},{"issue":"6376","key":"10.1016\/j.intimp.2023.110379_b0120","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1126\/science.aan4183","article-title":"Defective cholesterol clearance limits remyelination in the aged central nervous system","volume":"359","author":"Cantuti-Castelvetri","year":"2018","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.intimp.2023.110379_b0125","doi-asserted-by":"crossref","first-page":"825","DOI":"10.3390\/cells8080825","article-title":"The molecular basis for remyelination failure in multiple sclerosis","volume":"8","author":"Gruchot","year":"2019","journal-title":"Cells"},{"issue":"10","key":"10.1016\/j.intimp.2023.110379_b0130","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.3390\/cells9102145","article-title":"TNF production and release from microglia via extracellular vesicles: impact on brain functions","volume":"9","author":"Raffaele","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.intimp.2023.110379_b0135","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.605673","article-title":"Shared and unique features of human interferon-beta and interferon-alpha subtypes","volume":"11","author":"Wittling","year":"2021","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.intimp.2023.110379_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108835","article-title":"Multiple sclerosis risk gene Mertk is required for microglial activation and subsequent remyelination","volume":"34","author":"Shen","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.intimp.2023.110379_b0145","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.724718","article-title":"Progress in the Application of Drugs for the Treatment of Multiple Sclerosis","volume":"12","author":"Wei","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"10","key":"10.1016\/j.intimp.2023.110379_b0150","doi-asserted-by":"crossref","first-page":"e0185931","DOI":"10.1371\/journal.pone.0185931","article-title":"A systematic review of the effectiveness of self-management interventions in people with multiple sclerosis at improving depression, anxiety and quality of life","volume":"12","author":"Kidd","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2023.110379_b0155","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.msard.2018.08.009","article-title":"Promising effect of rapamycin on multiple sclerosis","volume":"26","author":"Bagherpour","year":"2018","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.intimp.2023.110379_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-015-0306-7","article-title":"Unraveling the hygiene hypothesis of helminthes and autoimmunity: origins, pathophysiology, and clinical applications","volume":"13","author":"Versini","year":"2015","journal-title":"BMC Med."},{"issue":"9","key":"10.1016\/j.intimp.2023.110379_b0165","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/ni1376","article-title":"Interleukin 27 negatively regulates the development of interleukin 17\u2013producing T helper cells during chronic inflammation of the central nervous system","volume":"7","author":"Stumhofer","year":"2006","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2023.110379_b0170","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.msard.2017.04.004","article-title":"Is Toxoplasma gondii infection protective against multiple sclerosis risk?","volume":"15","author":"Koskderelioglu","year":"2017","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.intimp.2023.110379_b0175","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jneuroim.2015.05.011","article-title":"Toxoplasma gondii seropositivity is negatively associated with multiple sclerosis","volume":"285","author":"Stascheit","year":"2015","journal-title":"J. Neuroimmunol."},{"issue":"1\u20132","key":"10.1016\/j.intimp.2023.110379_b0180","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jaut.2012.01.001","article-title":"Prevalence of anti-Toxoplasma antibodies in patients with autoimmune diseases","volume":"39","author":"Shapira","year":"2012","journal-title":"J. Autoimmun."},{"issue":"12","key":"10.1016\/j.intimp.2023.110379_b0185","first-page":"1578","article-title":"Frequency of blood-tissue parasitic infections in patients with multiple sclerosis, as compared to their family members","volume":"5","author":"Pestehchian","year":"2014","journal-title":"Int. J. Prev. Med."},{"issue":"2","key":"10.1016\/j.intimp.2023.110379_b0190","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1556\/1886.2019.00020","article-title":"Toxoplasma gondii infection and multiple sclerosis: an age-and a gender-matched case-control seroprevalence study","volume":"10","author":"M\u00e9ndez-Hern\u00e1ndez","year":"2020","journal-title":"Eur. J. Microbiol. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2023.110379_b0195","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1111\/ene.15055","article-title":"Toxoplasma gondii and multiple sclerosis: A systematic review and meta-analysis","volume":"28","author":"Cicero","year":"2021","journal-title":"Eur. J. Neurol."},{"issue":"2","key":"10.1016\/j.intimp.2023.110379_b0200","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1084\/jem.20062175","article-title":"Conventional T-bet+ Foxp3\u2212 Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection","volume":"204","author":"Jankovic","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2023.110379_b0205","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s13311-020-00957-9","article-title":"Chronic Toxoplasma gondii infection alleviates experimental autoimmune encephalomyelitis by the immune regulation inducing reduction in IL-17A\/Th17 via upregulation of SOCS3","volume":"18","author":"Ham","year":"2021","journal-title":"Neurotherapeutics"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923007026?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923007026?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T18:00:07Z","timestamp":1761588007000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923007026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":41,"alternative-id":["S1567576923007026"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110379","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toxoplasma gondii attenuates the ethidium bromide induced demyelination lesions in multiple sclerosis model rats","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110379","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110379"}}